Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Microchimerism maintains deletion of the donor cell–specific CD8+ T cell repertoire
Weldy V. Bonilla, Markus B. Geuking, Peter Aichele, Burkhard Ludewig, Hans Hengartner, Rolf M. Zinkernagel
Weldy V. Bonilla, Markus B. Geuking, Peter Aichele, Burkhard Ludewig, Hans Hengartner, Rolf M. Zinkernagel
View: Text | PDF
Research Article Immunology

Microchimerism maintains deletion of the donor cell–specific CD8+ T cell repertoire

  • Text
  • PDF
Abstract

Rare cases of stable allograft acceptance after discontinuation of immunosuppression are often accompanied by macrochimerism (> 1% donor cells in blood) or microchimerism (< 1% donor cells in blood). Here, we have investigated whether persistence of donor cells is the cause or the consequence of long-lasting CTL unresponsiveness. We found that engraftment of splenocytes bearing a single foreign MHC class I–restricted epitope resulted in lifelong donor cell microchimerism and specific CTL unresponsiveness. This status was reversed in a strictly time- and thymus-dependent fashion when the engrafted cells were experimentally removed. The results presented herein show that microchimerism actively maintains CTL unresponsiveness toward a minor histocompatibility antigen by deleting the specific repertoire and thus excluding dominant, T cell extrinsic mechanisms of CTL unresponsiveness independent of systemically persisting donor cell antigen.

Authors

Weldy V. Bonilla, Markus B. Geuking, Peter Aichele, Burkhard Ludewig, Hans Hengartner, Rolf M. Zinkernagel

×

Figure 2

H8 chimerism-induced antigen-specific CTL unresponsiveness.

Options: View larger image (or click on image) Download as PowerPoint
H8 chimerism-induced antigen-specific CTL unresponsiveness.
(A–D) Sex-ma...
(A–D) Sex-matched H8 splenocytes were adoptively transferred to B6 mice. At the indicated time points (A) or 28 days after transfer (C and D), recipient and control mice without cell transfer were infected with LCMV. (A) At 8 to 9 days after infection with LCMV, splenocytes were tested for GP33-specific (filled circles) and NP396-specific (filled triangles) CTL activity in a standard primary ex vivo CTL assay. Uncoated EL-4 target cells (open circles) are shown at the highest effector to target ratio. Each line represents an individual mouse. One representative experiment of 3 (day 45) or 2 (day 300) is shown. (B) DNA was isolated from blood samples taken from chimeric recipients on days 45 and 300 as shown in Figure 2A. The presence of H8 chimerism was confirmed by H8-specific PCR analysis. (C) Frequencies of GP33- and NP396-specific CD8+ T cells in spleen 8 days after LCMV infection were enumerated using MHC class I H-2DbGP33 (black bars) and H-2DbNP396 (white bars) tetramers. (D) Splenocytes from the same mice as in C were tested for IFN-γ production upon restimulation with GP33 or NP396 or without restimulation. Representative FACS plots are shown, and bars indicate the mean ± SD of 3 mice (C and D).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts